In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Endo International plc

https://www.endo.com/

Latest From Endo International plc

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.

Clinical Trials Companies

China Biotech Podcast: BIOSECURE Updates, Genmab/ProfoundBio Deal

In this mixed Chinese- and English-language episode, guest speaker Treehill Partners co-founder Ali Pashadezah joins Brian Yang and Dexter Yan to discuss updates on the proposed BIOSECURE Act in the US Congress and US-China biotech movements. Also discussed is how Chinese biotechs are becoming acquisition targets for overseas biotech companies, including the recent purchases of Profound by Genmab and AnHeart Theraputics by Nuvantion.

China United States

Australian Teeth Whitener Marketer Frowns On Industry Self-Regulation Referencing US Laws

HiSmile appeals NAD recommendation following review on P&G challenge to discontinue ad claims on its website and in social media videos stating peroxide-containing whitening products are “painful” or cause pain, break down and impact gums and teeth, or “damage” gums.

Ad Complaints OTC Drugs

Endo Slams FDA’s ‘Improper Rationalization’ In Adrenalin Rival’s ‘Unlawful Approval’

Endo’s Par subsidiary insists that long-existing statute for US patent infringement cases should hold off final approval for a supplemental rival to its Adrenalin treatment for anaphylaxis for several years – in contrast to the FDA granting a recent approval to BPI Labs.

Legal Issues Intellectual Property
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • American Medical Systems, Inc.
    • Anchen Pharmaceuticals, Inc.
    • ASTORA Women's Health
    • Auxilium Pharmaceuticals, Inc. (Actient Pharmaceuticals LLC
    • Slate Pharmaceuticals)
    • DAVA Pharmaceuticals, Inc
    • Edict Pharmaceuticals Private Limited
    • Endo Finance LLC
    • Endo Health Solutions Inc.
    • Endo Pharmaceuticals Holdings Inc.
    • Endo Ventures Limited
    • HealthTronics, Inc.
    • Indevus Pharmaceuticals, Inc.
    • JHP Pharmaceuticals, LLC
    • Paladin Labs Inc. (Allon Therapeutics, Inc.
    • Ativa Pharma S.A,
    • Labopharm Inc.
    • Triton Pharma, Inc.
    • ViRexx Medical Corp.)
    • Par Pharmaceutical Companies, Inc.
    • Par Pharmaceutical, Inc.
    • Penwest Pharmaceuticals Co.
    • Qualitest Pharmaceuticals
    • Strativa Pharmaceuticals
    • Valera Pharmaceuticals
UsernamePublicRestriction

Register